Skip to main content

Ransomware victim disclosure

All victims

Viking Therapeutics

Claimed by ALPHV/BlackCat · listed 3 years ago

31m
Age
since listed · data leaked

Status timeline

  1. ListedDec 19, 2023
  2. Data leakeddate unknown

At a glance

Status
Data leaked
Listed on leak site
Dec 19, 2023

About the victim

AI dossier — public-source company profile

Viking Therapeutics is a clinical-stage biopharmaceutical company founded in 2012 and headquartered in San Diego, California. The company develops novel therapies for metabolic and endocrine disorders, with lead programs including VK2735 (a dual GLP-1/GIP receptor agonist in Phase 3 obesity trials) and VK2809 (a thyroid hormone receptor beta agonist).

Industry
Biopharmaceutical Development
Address
9920 Pacific Heights Blvd, Suite 500, San Diego, CA 92121
Founded
2012

Attack summary

Severity: low — No proof files, screenshots, or operational impact are advertised. The post contains only a corporate description with no evidence of data exfiltration, encryption, or threat to specific assets. This appears to be a listing/announcement without substantiation.

The leak post does not describe any specific attack claims, encryption activity, or data exfiltration. Only a company description is provided without operational details of the alleged breach.

low

What the group claims

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Sources

Source

Indexed 3 years ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About ALPHV/BlackCat

ALPHV, also known as BlackCat or Noberus, is a sophisticated ransomware-as-a-service operation that emerged in November 2021 and quickly became one of the most prolific ransomware groups globally, driven by financial motivations and responsible for compromising over 930 victims worldwide. The group is believed to be operated by Russian-speaking cybercriminals and represents an evolution of the BlackMatter ransomware operation, operating under a RaaS model that recruits experienced affiliates from other disbanded ransomware groups. ALPHV employs a multi-faceted attack methodology utilizing various initial access vectors including compromised Remote Desktop Protocol credentials, phishing campaigns, and exploitation of unpatched vulnerabilities, followed by deployment of their Rust-based ransomware payload that supports both Windows and Linux environments, while consistently employing double extortion tactics that involve data theft prior to encryption and threats to publish stolen information on their leak site. Notable campaigns include high-profile attacks against critical infrastructure and major corporations across healthcare, finance, and energy sectors, with the group demanding ransoms ranging from hundreds of thousands to millions of dollars, prompting the FBI and CISA to issue multiple advisories warning of their targeting of critical infrastructure organizations. As of early 2024, ALPHV remains active despite ongoing law enforcement efforts, continuing to evolve their tactics and maintain their position as one of the most significant ransomware threats globally. The group has been linked to 1,662 public disclosures across our corpus. First observed on a leak site on September 9, 2021; most recent post March 3, 2024. The operation is currently inactive.

Also tracked as: ALPHV, BlackCat, Noberus.

Timeline of this disclosure

  • December 19, 2023Viking Therapeutics listed by ALPHV/BlackCaton the group's public leak site

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,600 disclosures indexed across all operators we track. Geographically, Viking Therapeutics is reported in United States, a country with 11,033 ransomware disclosures in our corpus.

If your organisation is affected

A listing by ALPHV/BlackCat means Viking Therapeutics appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

  • Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
  • Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
  • Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
  • Report the incident to your national CERT, CISA (United States), as required for your jurisdiction.
  • Monitor for the data appearing on ALPHV/BlackCat's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.